<DOC>
	<DOC>NCT01754766</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of AGN-229666 for the treatment of allergic conjunctivitis.</brief_summary>
	<brief_title>AGN-229666 for the Treatment of Allergic Conjunctivitis</brief_title>
	<detailed_description />
	<mesh_term>Conjunctivitis</mesh_term>
	<mesh_term>Conjunctivitis, Allergic</mesh_term>
	<criteria>Japanese patients living in Japan with a history of allergic conjunctivitis Willing to discontinue wearing contact lenses during the study period Use of nicotine products during the study period Presence of active eye infection (bacterial, viral, or fungal) History of an ocular herpetic infection Eye surgery intervention within 3 months and/or a history of refractive surgery within the past 6 months</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2013</verification_date>
</DOC>